AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Revenue

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202561-17.99%
Mar 31, 202475+390.55%
Mar 31, 202315+198.49%
Mar 31, 20225-79.45%
Mar 31, 202125+34.25%
Mar 31, 202019-32.17%
Mar 31, 201927-27.84%
Mar 31, 201838-25.44%
Mar 31, 201751-27.92%
Mar 31, 201671+19.06%
Mar 31, 201559-30.88%
Mar 31, 201486+26.82%
Mar 31, 201368+10.35%
Mar 31, 201261

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)